Dr. PH Nadja Chernyak
Leiterin
Arbeitsgruppe Komplexe Intervention und ökonomische Evaluation
Mitarbeiterin
Institut für Versorgungsforschung und Gesundheitsökonomie
+49 211 3382-+49 (0) 211 81-06505
+49-(0)-211-81-06502
Ausgewählte Publikationen
- Brüne M, Linnenkamp U, Andrich S, Jaffan-Kolb L, Claessen H, Dintsios C-M, Schmitz-Losem I, Kruse J, Chernyak N, Hiligsmann M, Hermanns N, Icks A 2021. Health Care Use and Costs in Individuals With Diabetes With and Without Comorbid Depression in Germany: Results of the Cross-sectional DiaDec Study. Diabetes Care. 44: 407-415. https://doi.org/10.2337/dc19-2487
- Linnenkamp U, Gontscharuk V, Brüne M, Chernyak N, Kvitkina T, Arend W, Fiege A, Schmitz-Losem I, Kruse J, Evers SM. A. A. , Hiligsmann M, Hoffmann B, Andrich S, Icks A 2020. Using statutory health insurance data to evaluate nonresponse in a cross-sectional study on depression among patients with diabetes in Germany. Int J Epidemiol. 49: 629-637. https://doi.org/10.1093/ije/dyz278
- Brüne M, Andrich S, Haastert B, Kaltheuner M, Icks A 2020. New prescription of antihyperglycemic agents among patients with diabetes in Germany: Moderate concordance between health insurance data and self-reports. Pharmacoepidem Dr S. 30: 304-312. https://doi.org/10.1002/pds.5160